First Heartland Consultants’s Immunomedics Inc IMMU Stock Holding History

First Heartland Consultants’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-49,800	Closed	-$322K	–	361
2017 Q1	$322K	Buy	49,800 +13,000	+35%	+$65.9K	0.09%	240
2016 Q4	$135K	Buy	36,800 +17,300	+89%	+$51.2K	0.04%	313
2016 Q3	$63K	Hold	19,500	–	–	0.02%	318
2016 Q2	$45	Buy	+19,500	New	+$65.2K	﹤0.01%	297
2015 Q3	–	Sell	-30,695	Closed	-$125	–	285
2015 Q2	$125	Hold	30,695	–	–	0.03%	251
2015 Q1	$118K	Hold	30,695	–	–	0.05%	244
2014 Q4	$147K	Hold	30,695	–	–	0.06%	235
2014 Q3	$114K	Hold	30,695	–	–	0.05%	240
2014 Q2	$112K	Hold	30,695	–	–	0.05%	245
2014 Q1	$129K	Hold	30,695	–	–	0.06%	235
2013 Q4	$141K	Buy	30,695 +15,777	+106%	+$70.3K	0.08%	190
2013 Q3	$102K	Hold	14,918	–	–	0.06%	217
2013 Q2	$81K	Buy	+14,918	New	+$49K	0.05%	247

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Heartland Consultants's IMMU Position: Q2 2017 in Review

First Heartland Consultants sold out of Immunomedics Inc (IMMU) in Q2 2017, closing a stake of 49,800 shares — an estimated $322K sold.

First Heartland Consultants first reported a position in IMMU in Q2 2013 and held it in 13 quarters. The position peaked at $322K in Q1 2017. 130 funds tracked by Wall St. Rank hold IMMU as of Q2 2017.

First Heartland Consultants reported no remaining Immunomedics Inc position as of Q2 2017 after selling out during the quarter.
First Heartland Consultants sold 49,800 Immunomedics Inc shares in Q2 2017, an estimated $322K.
First Heartland Consultants first reported a position in Immunomedics Inc in Q2 2013 and held it in 13 quarters.
First Heartland Consultants's Immunomedics Inc position peaked at $322K in Q1 2017.
130 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2017.

Based on First Heartland Consultants's 13F filing for Q2 2017, filed 26 Jul 2017.